Psychological Factors Influencing Cancer Post-traumatic Growth (CEMA-P)

Centre Hospitalier de Valenciennes

Status: Enrolling

Conditions: Cancer

Treatments: Other: Interviews with a psychologist/psychiatrist

Study type: Interventional

Funder types: Other; NETWORK

Identifiers

NCT06278558

2023-02-01

Details and patient eligibility

About

The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.

Enrollment: 289 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over 18 years of age
• Patients in the initial phase of curative treatment for a 1st solid cancer
• At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course)
• At less than 6 months from the initial diagnosis
• Patient having given written consent to participate in the study

Exclusion criteria

• Patients with a previous history of cancer
• Patients with incurable cancer progression, recurrence or relapse
• Metastatic, brain, hematological or skin cancer
• Patients who have difficulty understanding written French
• Patient psychologically or physically unable to answer questionnaires

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

289 participants in 1 patient group

Interviews with a psychologist/psychiatrist

Experimental group

Description:

Implementation of an interview with a psychologist or psychiatrist following a telephone conversation with patients with no psychological follow-up and a high HADS score (≥11), at all stages of the study (start of chemotherapy T1, end of chemotherapy T2, 6 months after the end of chemotherapy).

Treatment:

Other: Interviews with a psychologist/psychiatrist